Global Blood: Q4 Earnings Snapshot

February 23, 2022 GMT

SOUTH SAN FRANCISCO, Calif. (AP) _ Global Blood Therapeutics Inc. (GBT) on Wednesday reported a loss of $87.6 million in its fourth quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of $1.36.

The results missed Wall Street expectations. The average estimate of 15 analysts surveyed by Zacks Investment Research was for a loss of $1.14 per share.

The biopharmaceutical company posted revenue of $56.1 million in the period, beating Street forecasts. Thirteen analysts surveyed by Zacks expected $55.5 million.

For the year, the company reported that its loss widened to $303.1 million, or $4.81 per share. Revenue was reported as $194.7 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on GBT at